Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Nucleonics Inc
Profile last edited on: 4/23/18      CAGE:       UEI:

Business Identifier: Novel RNA interference-based therapeutics for viral and other diseases
Year Founded
2001
First Award
2002
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

13 Summit Square Center Suite 305
Langhorne, PA 19047
   (267) 518-0100
   info@nucleonicsinc.com
   www.nucleonicsinc.com
Location: Single
Congr. District: 01
County: Bucks

Public Profile

Nucleonics, Inc., a biotechnology company, develops RNAi therapeutics for viral and other diseases. It offers NUC-B1000, a hepatitis B antiviral agent. The company also focuses on the development of eiRNA-based therapeutics for chronic hepatitis B and hepatitis C infections.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$97,667
Phase II Dollars
$0
Total Awarded
$97,667

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 1 NIH $97,667
Project Title: Identification of novel antiviral targets using RNAi

Key People / Management

  Robert Towarnicki -- President

  Barbara Guido

Company News

There are no news available.